Journals / Viral Hepatitis Journal / 2018 / Cilt: 24 - Sayı: 1

Epidemiology of Hepatitis C in North Cyprus

Kuzey Kıbrıs’ta Hepatit C Epidemiyolojisi

Pages
21–23
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The aim of this studywas to review the HCV epidemiology in the TRNC in the light of thecurrent data.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Hepatitis C virus (HCV) is known as the main etiological agent ofchronic liver disease, cirrhosis and hepatocellular carcinoma.
📊
Key Findings & Data:Studieson the Turkish Republic of North Cyprus (TRNC) population havereported that the HCV prevalence was between 0% and 1%.
💡
Conclusion & Impact:The aim of this studywas to review the HCV epidemiology in the TRNC in the light of thecurrent data.
🔬Design:Review & Systematic Survey
📍Scope:2017 Verileri
⚙️Variables:Domain Parameters

Abstract

Hepatitis C virus (HCV) is known as the main etiological agent ofchronic liver disease, cirrhosis and hepatocellular carcinoma. Studieson the Turkish Republic of North Cyprus (TRNC) population havereported that the HCV prevalence was between 0% and 1%. Thelow prevalence of HCV in the TRNC is a result of the small islandpopulation and the fact that HCV-positive individuals were notallowed to reside in the TRNC until 2017. However, it is likely thatthere will be an increase in HCV seroprevalence going forward dueto relapses and cases of illegal immigration. The aim of this studywas to review the HCV epidemiology in the TRNC in the light of thecurrent data.

Özet

Hepatit C virüsü (HCV), kronik karaciğer, siroz ve hepatosellüler karsinoma etkeni olduğu bilinmektedir. Kuzey Kıbrıs Türk Cumhuriyeti’nde (KKTC) yapılan çalışmalar prevelansın %0-1 arasında olduğunu göstermektedir. Ülkemizde HCV insidansının düşük olmasının nedeni nüfus olarak küçük bir ada olmamız ve HCV pozitif olgulara 2017 yılına kadar KKTC’de ikamet etme izninin verilmemesi olduğunu ve HCV için yapılan düzenlemenin sonucunda relaps olguların ve ayrıca adada illegal kesimin bulunduğu göz önüne alınırsa HCV seroprevelansında da artış olabileceğini düşünmekteyiz. Bu makalede, KKTC’deki HCV epidemiyolojinin güncel literatür ile birikte gözden geçirilmesi amaçlanmıştır.

🔖

Cite This Article

GÜVENİR, M., SÜER, K. (2022). Epidemiology of Hepatitis C in North Cyprus. Viral Hepatitis Journal, Cilt: 24 - Sayı: 1, 21–23. https://ajindex.com/articles/646400

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (8)

  1. Triantos C, Konstantakis C, Tselekouni P, Kaafateli M, Aggeletopoulou I, Manolakopoulos S. Epidemiology of hepatitis C in Greece. World J Gastroenterol. 2016;22:8094-8102. Demetriou VL, van de Vijver DA; Cyprus HCV Network, Kostrikis LG. Molecular epidemioogy of hepatitis C infection in Cyprus: evidence of polyphyletic infection. J Med Virol. 2009;81:238- 248. Ghaderi-Zefrehi H, Gholami-Fesharaki M, Sharafi H, Sadeghi F, Alavian SM. The Distribution of Hepatitis C Virus Genotypes in Middle Eastern Countries: A systemic Review and Meta-Analysis. Hepat Mon. 2016;16:e40357. Güner R, Kayaaslan B. Current Treatment Approach in Acute Hepatitis C Infection. Viral Hepat J. 2017;23:1-5. World Health Organization. Global Hepatitis Report 2017.
  2. Gower E, Estes C, Blach S, Razavi-Shearer K, Razavi H. Global Epidemiology and genotype distribution of the hepatitis C virus infection. J Hepatol. 2014;61(Suppl):45-57.
  3. Petruzziello A, Marigliano S, Loquercio G, Cozzolino A, Cacciapuoti C. Global epidemiology of hepatitis C virus infection: An up-date of the distribution and circulation of hepatitis C virus genotypes. World J Gastroenterol. 2016;22:7824-7840.
  4. Petruzziello A, Marigliano S, Loquercio G, Cacciapuoti C. Hepatitis C virus (HCV) genotypes distribution: an epidemiological up-date in Europe. Infectious Agents and Cancer. 2016;11:53. Fallahian F, Najafi A. Epidemiology of Hepatitis C in the Middle East. Saudi J Kindey Dİs Transpl. 2011;22:1-9.
  5. Demetriou VL, Kosktrikis LG. Molecular epidemiology of hepatitis C infection in Cyprus within the general population and high-risk cohorts. BMC Res Notes. 2011;4:468. Altındis M, Yilmaz S, Dikengil T, Acemoglu H, Hosoglu S. Seroprevalence and genotyping of hepatitis B, hepatitis C and HIV among health population and Turkish sodires in Northern Cyprus. World J Gastroenterol. 2006;12:6792-6796.
  6. Ashkani-Esfahani S, Alavian SM, Salehi-Marzijarani M. Prevalence of hepatitis C virus infection among hemodialysis patients in the Middle-East: A systemic review and meta-analysis. World J Gastroenterol. 2017;23:151-166.
  7. Lazarus JV, Sperle I, Spina A, Rockstroh JK. Are the testing needs of key European population affected by hepatitis B and hepatitis C being addressed ? A scoping review of testing studies in Europe. Croat Med J. 2016;57:442-456.
  8. Süer K, Güvenir M, Güler E, Diktaş H. Evaluation of HBsAg, AntiHCV, Anti-HIV and Syphilis Test Results among the Blood Donors Admitted to the Near East University Hospital in Turkish Republic of Nor